VUSE - ETF AI Analysis

Top Page

Vident Core US Equity Fund (VUSE)

Rating:74Outperform

Price Target:―

VUSE, the Vident Core US Equity Fund, earns a solid overall rating thanks to strong, diversified leaders like Alphabet, Walmart, Apple, and Broadcom, which all show robust financial performance, positive earnings commentary, and strategic positioning in growth areas such as AI, cloud, e-commerce, and services. Some holdings like AbbVie, Eli Lilly, Visa, and Nvidia introduce risks through high valuations, leverage or cash flow concerns, and occasional bearish technical signals, and the fund’s notable exposure to high-growth, AI-focused and large-cap tech names means investors should be aware of valuation and momentum risk if growth expectations cool.

Positive Factors

Strong Blue-Chip Core

Several top holdings like Alphabet, Walmart, Eli Lilly, Lam Research, Johnson & Johnson, and Costco have shown strong or steady performance, helping support the fund despite recent market weakness.

Broad Sector Diversification

The ETF spreads its investments across many sectors, including technology, financials, health care, consumer stocks, and more, which helps reduce the impact if any one area of the market struggles.

Meaningful Fund Size

With hundreds of millions in assets under management, the fund is large enough to offer stability and efficient trading for most everyday investors.

Negative Factors

Recent Weak Performance

The ETF has delivered slightly negative returns over the past month, three months, and year to date, showing it has recently lagged the broader market.

Higher-Than-Index Expense Ratio

The fund’s expense ratio is noticeably higher than many low-cost core U.S. equity index ETFs, which can slowly reduce investors’ net returns over time.

Heavy U.S. and Technology Exposure

Almost all assets are invested in U.S. stocks with a large tilt toward technology, which increases sensitivity to downturns in the U.S. market and the tech sector.

VUSE vs. SPDR S&P 500 ETF (SPY)

AUM627.05M

RegionNorth America

Expense Ratio0.50%

Beta0.97

IssuerVident

Inception DateJan 21, 2014

Dividend Yield0.47%

Asset ClassEquity

Index TrackedVident Core U.S. Stock Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume13,507

30 Day Avg. Volume24,121

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

81.11

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering126

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

VUSE Summary

VUSE (Vident Core US Equity Fund) is an ETF that follows the Vident Core U.S. Stock Index, aiming to give you broad exposure to the entire U.S. stock market. It holds many types of companies, from smaller up-and-coming businesses to large, well-known names like Alphabet (Google’s parent company) and Walmart, across sectors such as technology, health care, and consumer goods. Someone might invest in VUSE for simple, one-stop diversification across U.S. stocks and the potential for long-term growth. A key risk is that its value can rise and fall with the overall U.S. stock market, especially tech-heavy periods.

How much will it cost me?The Vident Core US Equity Fund (VUSE) has an expense ratio of 0.5%, which means you’ll pay $5 per year for every $1,000 invested. This is higher than average for ETFs because it uses an actively managed strategy that focuses on optimizing risk-adjusted returns through proprietary factors. Active management typically involves more research and decision-making, which can lead to higher costs.

What would affect this ETF?VUSE's heavy exposure to technology and consumer sectors could benefit from innovation and consumer spending trends, especially if economic conditions remain strong and interest rates stabilize. However, rising interest rates or regulatory changes in tech and healthcare could negatively impact its top holdings like Apple, Meta, and Eli Lilly. Additionally, broader economic slowdowns or sector-specific challenges could affect its diverse portfolio across U.S. equities.

VUSE Top 10 Holdings

VUSE leans heavily into U.S. large caps, with a clear tilt toward tech and health care names that set the tone for returns. Lam Research has been a standout, riding the AI hardware wave and giving the fund a strong push, while steady gains from Johnson & Johnson and Walmart add a defensive backbone. On the flip side, Eli Lilly and Visa have been losing a bit of steam lately, acting as mild brakes. Big Tech exposure via Alphabet, Apple, and Meta keeps the fund tied closely to the broader U.S. growth story.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ABBV	AbbVie	2.53%	$16.00M	$410.83B	10.25%	66 Neutral
AVGO	Broadcom	2.39%	$15.09M	$1.58T	85.44%	76 Outperform
GOOGL	Alphabet Class A	2.39%	$15.09M	$3.64T	74.57%	85 Outperform
LLY	Eli Lilly & Co	2.36%	$14.90M	$927.57B	7.72%	72 Outperform
NVDA	Nvidia	2.33%	$14.69M	$4.46T	65.81%	76 Outperform
MA	Mastercard	2.06%	$13.00M	$467.90B	-4.58%	75 Outperform
META	Meta Platforms	2.05%	$12.93M	$1.67T	5.20%	76 Outperform
V	Visa	2.04%	$12.91M	$609.54B	-7.08%	70 Outperform
ORCL	Oracle	2.04%	$12.91M	$444.88B	2.55%	66 Neutral
MSFT	Microsoft	2.04%	$12.90M	$3.05T	3.47%	79 Outperform

VUSE Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

66.18

Negative

100DMA

65.93

Positive

200DMA

64.68

Positive

Market Momentum

MACD

0.04

Negative

RSI

51.66

Neutral

STOCH

80.58

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VUSE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 65.61, equal to the 50-day MA of 66.18, and equal to the 200-day MA of 64.68, indicating a neutral trend. The MACD of 0.04 indicates Negative momentum. The RSI at 51.66 is Neutral, neither overbought nor oversold. The STOCH value of 80.58 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VUSE.

VUSE Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
VUSE	―	―	$627.05M	0.50%	74 Outperform
ULTY	―	―	$975.90M	1.30%	60 Neutral
SYLD	―	―	$924.75M	0.59%	69 Neutral
AUSF	―	―	$847.92M	0.27%	71 Outperform
PFM	―	―	$768.31M	0.52%	73 Outperform
HLAL	―	―	$756.29M	0.50%	76 Outperform

Performance Comparison

VUSE

Vident Core US Equity Fund

65.25

7.16

12.33%

ULTY

YieldMax Ultra Option Income Strategy ETF

―

SYLD

Cambria Shareholder Yield ETF

―

AUSF

Global X Adaptive U.S. Factor ETF

―

PFM

Invesco Dividend Achievers ETF

―

HLAL

Wahed FTSE USA Shariah ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents